Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia, the ANGIOCOR prospective cohort study protocol

  • Ullmo, Johana|||0000-0002-9313-917X
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Bos-Real, L.|||0000-0002-6159-0644
  • Fernandez-Llama, Patricia|||0000-0002-7472-2124
  • Calero, Francesca|||0000-0002-5758-0769
  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Trilla, Cristina|||0000-0002-5650-1790
  • Carreras Costa, Francesc|||0000-0002-1944-0562
  • Sionis, Alessandro|||0000-0003-0843-9512
  • Mora, J.
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Cardiovascular diseases (CVD) are cause of increased morbidity and mortality in spite of advances for diagnosis and treatment. Changes during pregnancy affect importantly the maternal CV system. Pregnant women that develop preeclampsia (PE) have higher risk (up to 4 times) of clinical CVD in the short- and long-term. Predominance of an anti-angiogenic environment during pregnancy is known as main cause of PE, but its relationship with CV complications is still under research. We hypothesize that angiogenic factors are associated to maternal cardiac dysfunction/remodeling and that these may be detected by new cardiac biomarkers and maternal echocardiography. Methods: Prospective cohort study of pregnant women with high-risk of PE in first trimester screening, established diagnosis of PE during gestation, and healthy pregnant women (total intended sample size n = 440). Placental biochemical and biophysical cardiovascular markers will be assessed in the first and third trimesters of pregnancy, along with maternal echocardiographic parameters. Fetal cardiac function at third trimester of pregnancy will be also evaluated and correlated with maternal variables. Maternal cardiac function assessment will be determined 12 months after delivery, and correlation with CV and PE risk variables obtained during pregnancy will be evaluated. Discussion: The study will contribute to characterize the relationship between anti-angiogenic environment and maternal CV dysfunction/remodeling, during and after pregnancy, as well as its impact on future CVD risk in patients with PE. The ultimate goal is to improve CV health of women with high-risk or previous PE, and thus, reduce the burden of the disease. Trial registration: NCT04162236.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Obstetric outcomes of sars-cov-2 infection in asymptomatic pregnant women

  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Ferriols Pérez, Elena|||0000-0002-8003-0335
  • De La Cruz Conty, Maria Luisa
  • Caño Aguilar, Africa
  • Encinas Pardilla, Maria Begoña
  • Prats Rodriguez, Pilar|||0000-0001-9216-9118
  • Mune Hernando, Marta
  • Forcen Acebal, Laura
  • Pintado Recarte, Pilar
  • Medina Mallen, Maria del Carmen|||0000-0002-1219-5947
  • Perez Perez, Noelia
  • Canet Rodriguez, Judit|||0000-0001-7387-1462
  • Villazlba Yarza, Ana
  • Nieto Velasco, Olga|||0000-0001-8311-9442
  • Del Barrio Fernandez, Pablo Guillermo
  • Orizales Lago, Carmen María|||0000-0001-7184-2799
  • Marcos Puig, Beatriz
  • Muñoz Abellana, Begoña
  • Fuentes Ricoy, Laura
  • Rodriguez Vicente, Agueda
  • Janeiro Freire, Maria Jesus
  • Alferez Alvarez-Mallo, Macarena
  • Casanova Pedraz, Cristina
  • Alomar Mateu, Onofre
  • Lesmes Heredia, Cristina|||0000-0002-6857-3935
  • Wizner de Alva, Juan Carlos
  • Posadas San Juan, Alma
  • Macia Badia, Montserrat
  • Alvarez Colomo, Cristina
  • Sanchez Muñoz, Antonio
  • Pratcorona Alicart, Laia|||0000-0002-3805-1589
  • Alonso Saiz, Ruben
  • Lopez Rodriguez, Monica|||0000-0001-8134-9682
  • Barbancho Lopez, Maria Carmen
  • Meca Casbas, Marta Ruth
  • Vaquerizo Ruiz, Oscar
  • Moran Antolin, Eva
  • Nuñez Valera, Maria Jose
  • fernandez Fernandez, Camino
  • Tubau Navarra, Albert|||0000-0001-5460-0763
  • Cano Garcia, Alejandra Maria
  • Soldevilla Perez, Susana
  • Gattaca Abasolo, Irene
  • Adanez Garcia, Jose
  • Puertas Prieto, Alberto
  • Ostos Serna, Rosa
  • Guadix Martin, Maria del Pilar
  • Catalina Coello, Monica
  • Espuelas Malon, Silvia
  • Sainz Bueno, Jose Antonio
  • Granell Escobar, Maria Reyes|||0000-0002-7553-1688
  • Cruz Melguizo, Sara
  • Martinez Perez, Oscar|||0000-0002-1457-3446
Around two percent of asymptomatic women in labor test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Spain. Families and care providers face childbirth with uncertainty. We determined if SARS-CoV-2 infection at delivery among asymptomatic mothers had different obstetric outcomes compared to negative patients. This was a multicenter prospective study based on universal antenatal screening for SARS-CoV-2 infection. A total of 42 hospitals tested women admitted for delivery using polymerase chain reaction, from March to May 2020. We included positive mothers and a sample of negative mothers asymptomatic throughout the antenatal period, with 6-week postpartum follow-up. Association between SARS-CoV-2 and obstetric outcomes was evaluated by multivariate logistic regression analyses. In total, 174 asymptomatic SARS-CoV-2 positive pregnancies were compared with 430 asymptomatic negative pregnancies. No differences were observed between both groups in key maternal and neonatal outcomes at delivery and follow-up, with the exception of prelabor rupture of membranes at term (adjusted odds ratio 1.88, 95% confidence interval 1.13-3.11; p = 0.015). Asymptomatic SARS-CoV-2 positive mothers have higher odds of prelabor rupture of membranes at term, without an increase in perinatal complications, compared to negative mothers. Pregnant women testing positive for SARS-CoV-2 at admission for delivery should be reassured by their healthcare workers in the absence of symptoms.